Home
Search

Policy

BIO advocates for laws, funding and other governmental actions that ensure that biotechnology companies are able to focus on their research to drive the future of innovation.

Press Releases
Browse all Press Releases
U.S. Bioscience Industry Powers Over $3 Trillion in Economic Output, New Report Finds
October 28, 2026
WASHINGTON, DC (October 28, 2026) – Today, the Biotechnology Innovation Organization (BIO) and the Council of State Bioscience Associations (CSBA) released new national and state-level data on the U.S. bioscience industry’s economic impact.The report, “The U.S. Bioscience Economy:…
BIO Statement on Proposed Rule to Implement Comprehensive Outbound Investment National Security (COINS) Act
October 22, 2026
WASHINGTON, D.C. – John F. Crowley, President and CEO of the Biotechnology Innovation Organization (BIO), released the following statement on the proposed Outbound Investment Security Program (OISP) rule:"The Administration is correct that biotechnology is a strategic technology industry for the…
BIO Statement on the FDA’s ‘Fit-for-Purpose Rare Disease Framework Initiative.’
October 14, 2026
WASHINGTON, D.C. – John F. Crowley, President and CEO of the Biotechnology Innovation Organization (BIO), released the following statement on the FDA’s ‘Fit-for-Purpose Rare Disease Framework Initiative.’“Today’s announcement is an important step toward advancing regulatory approaches that better…